stockportfolio.pro
DGX vs STE: Which Stock Is the Better Buy?
Quest Diagnostics Incorporated and STERIS plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — DGX vs STE, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Quest Diagnostics Incorporated (DGX) | STERIS plc (STE) | |
|---|---|---|
| Market cap | $23.9B | $21.3B |
| Revenue (latest FY) | $11.04B | $5.94B |
| Net income (latest FY) | $992.00M | $782.30M |
| Revenue growth (5y CAGR) | 3.2% | 13.8% |
| Net margin | 9.0% | 13.2% |
| Return on equity | 13.8% | 10.9% |
| P/E ratio | 23.8 | 27.6 |
| Dividend yield | 1.6% | 1.1% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full DGX vs STE breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open DGX's full financials → Open STE's full financials →More comparisons
Frequently asked questions
Which is bigger, DGX or STE?
Quest Diagnostics Incorporated is larger by market capitalization — $23.9B versus $21.3B.
Which grows faster, DGX or STE?
Over the last five fiscal years, STERIS plc grew revenue faster — 13.8%/yr versus 3.2%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.